CEO Steve Couldwell resigns from Tissue Regenix due to illness

Writer,

Regenerative medical devices company Tissue Regenix Group said that CEO Steve Couldwell had resigned his position 'with immediate effect' due to a recurrence of illness.

The firm said John Samuel would resume the position of executive chairman until a full time CEO appointment was made while COO Gareth Jones would take up the position of interim- CEO.

Mike Barker would continue to support the executive team as interim finance director.

At 9:45am: (LON:TRX) Tissue Regenix Group PLC share price was 0p at 3.75p


Related content

Tissue Regenix inks collaboration agreement for new tissue repair product

Regenerative medicine company Tissue Regenix said it had entered a manufacturing collaboration with a healthcare company to develop a new product line that addresses orthopaedic...

Mon, 11/05/2020 - 08:01


Tissue Regenix gets additional US government backed loan

Regenerative medical devices company Tissue Regenix said it had received a further $417k loan under the US government-backed Covid-19 business support scheme.

The funding was...

Mon, 20/04/2020 - 08:44


Tissue Regenix secures loan but warns of potential funding shortage by July

Regenerative medical devices company Tissue Regenix said it had secured a US government backed loan of $629k to assist with the potential impact of the...

Wed, 15/04/2020 - 07:43


Tissue Regenix executive chairman John Samuel stands down.

Regenerative medical devices company Tissue Regenix said executive chairman John Samuel had stood down.

Current director Jonathan Glenn had been appointed as chairman on an...

Fri, 20/03/2020 - 08:48


Tissue Regenix revenue up 12%; still seeking alternative funding

Regenerative medical devices company Tissue Regenix said it would post annual revenue growth of 12% and was continuing to assess various funding options to alleviate...

Wed, 22/01/2020 - 07:41